Variant report

Variant	esv33509
Chromosome Location	chr20:23705081-23777052
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr20:23715126-23715326	A549	lung:	n/a	chr20:23715271-23715282
2	CEBPB	chr20:23747045-23747345	HepG2	liver:	n/a	chr20:23747171-23747182 chr20:23747169-23747180 chr20:23747171-23747180 chr20:23747171-23747180 chr20:23747169-23747182 chr20:23747171-23747180 chr20:23747171-23747180 chr20:23747169-23747182
3	CEBPB	chr20:23710603-23710866	H1-hESC	embryonic stem cell:	n/a	chr20:23710701-23710712
4	CEBPB	chr20:23747026-23747352	A549	lung:	n/a	chr20:23747171-23747182 chr20:23747169-23747180 chr20:23747171-23747180 chr20:23747029-23747041 chr20:23747171-23747180 chr20:23747169-23747182 chr20:23747171-23747180 chr20:23747171-23747180 chr20:23747169-23747182
5	CEBPB	chr20:23710539-23710875	A549	lung:	n/a	chr20:23710701-23710712
6	CEBPB	chr20:23715136-23715338	IMR90	lung:	n/a	chr20:23715271-23715282
7	CEBPB	chr20:23710656-23710785	K562	blood:	n/a	chr20:23710701-23710712
8	CEBPB	chr20:23747142-23747274	K562	blood:	n/a	chr20:23747171-23747182 chr20:23747169-23747180 chr20:23747171-23747180 chr20:23747171-23747180 chr20:23747169-23747182 chr20:23747171-23747180 chr20:23747171-23747180 chr20:23747169-23747182
9	CEBPB	chr20:23715133-23715386	HepG2	liver:	n/a	chr20:23715271-23715282
10	CEBPB	chr20:23710550-23710870	IMR90	lung:	n/a	chr20:23710701-23710712
11	CEBPB	chr20:23710540-23710875	HepG2	liver:	n/a	chr20:23710701-23710712
12	CTCF	chr20:23754863-23755071	MCF-7	breast:	n/a	chr20:23754976-23754989
13	CTCF	chr20:23763120-23763270	GM12871	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
14	CTCF	chr20:23763120-23763270	GM12869	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
15	CTCF	chr20:23756740-23756890	HCPEpiC	choroid plexus:	n/a	chr20:23756767-23756780
16	CTCF	chr20:23762860-23763010	HFF	foreskin:	n/a	n/a
17	CTCF	chr20:23763220-23763370	WI-38	lung:	n/a	n/a
18	CTCF	chr20:23763074-23763319	GM13977	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
19	CTCF	chr20:23763080-23763230	AG04450	lung:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
20	CTCF	chr20:23763094-23763306	Hela-S3	cervix:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
21	CTCF	chr20:23763120-23763270	GM12866	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
22	CTCF	chr20:23729640-23729790	HEK293	kidney:	n/a	n/a
23	CTCF	chr20:23763120-23763270	GM12864	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
24	CTCF	chr20:23763089-23763335	GM19240	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
25	CTCF	chr20:23763140-23763290	Caco-2	colon:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
26	CTCF	chr20:23756660-23756810	MCF-7	breast:	n/a	chr20:23756767-23756780
27	CTCF	chr20:23719400-23719410	LNCaP	prostate:	n/a	n/a
28	CTCF	chr20:23729640-23729790	HCPEpiC	choroid plexus:	n/a	n/a
29	CTCF	chr20:23754918-23755032	NHEK	skin:	n/a	chr20:23754976-23754989
30	CTCF	chr20:23763090-23763322	Pancreas_OC	pancreas:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
31	CTCF	chr20:23763120-23763270	GM12868	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
32	CTCF	chr20:23763160-23763310	HRE	kidney:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
33	CTCF	chr20:23763120-23763270	HEEpiC	esophagus:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
34	CTCF	chr20:23763062-23763550	MCF-7	breast:	n/a	chr20:23763450-23763471 chr20:23763448-23763466 chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210 chr20:23763449-23763465
35	CTCF	chr20:23763116-23763277	SK-N-SH_RA	brain:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
36	CTCF	chr20:23763240-23763390	BE2_C	brain:	n/a	n/a
37	CTCF	chr20:23763120-23763270	HAc	cerebellar:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
38	CTCF	chr20:23763066-23763334	LNCaP	prostate:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
39	CTCF	chr20:23763120-23763270	HA-sp	spinal cord:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
40	CTCF	chr20:23763140-23763290	GM12871	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
41	CTCF	chr20:23704940-23705090	HAc	cerebellar:	n/a	n/a
42	CTCF	chr20:23742005-23742067	Lung_OC	lung:	n/a	n/a
43	CTCF	chr20:23763113-23763295	Lung_OC	lung:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
44	CTCF	chr20:23763056-23763310	GM10266	blood:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
45	CTCF	chr20:23763039-23763574	MCF-7	breast:	n/a	chr20:23763450-23763471 chr20:23763448-23763466 chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210 chr20:23763449-23763465
46	CTCF	chr20:23756684-23756859	H1-hESC	embryonic stem cell:	n/a	chr20:23756767-23756780
47	CTCF	chr20:23729821-23729900	GM13977	blood:	n/a	n/a
48	CTCF	chr20:23763020-23763170	HCM	heart:	n/a	n/a
49	CTCF	chr20:23763120-23763270	WERI-Rb-1	eye:	n/a	chr20:23763195-23763204 chr20:23763194-23763215 chr20:23763192-23763210
50	CTCF	chr20:23762900-23762938	A549	lung:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:23732873-23732923	SK-N-SH_RA	brain:	n/a
2	chr20:23732873-23732923	SK-N-SH_RA	brain:	n/a
3	chr20:23728814-23728864	NHDF-neo	bronchial:	n/a
4	chr20:23728432-23728482	HL-60	blood:	n/a
5	chr20:23728814-23728864	HCM	heart:	n/a
6	chr20:23728432-23728482	GM06990	blood:	n/a
7	chr20:23728432-23728482	NH-A	brain:	n/a
8	chr20:23731367-23731417	GM12891	blood:	n/a
9	chr20:23728814-23728864	AoSMC	blood vessel:	n/a
10	chr20:23732873-23732923	ECC-1	luminal epithelium:	n/a
11	chr20:23732595-23732645	HepG2	liver:	n/a
12	chr20:23728432-23728482	PANC-1	pancreas:	n/a
13	chr20:23728432-23728482	GM12891	blood:	n/a
14	chr20:23731367-23731417	SK-N-SH_RA	brain:	n/a
15	chr20:23728814-23728864	ProgFib	skin:	n/a
16	chr20:23728432-23728482	GM12892	blood:	n/a
17	chr20:23731367-23731417	HEK293	kidney:	embryo
18	chr20:23732595-23732645	NHDF-neo	bronchial:	n/a
19	chr20:23728432-23728482	GM19239	blood:	n/a
20	chr20:23731367-23731417	GM19239	blood:	n/a
21	chr20:23728432-23728482	NHBE	bronchial:	n/a
22	chr20:23728814-23728864	SK-N-MC	brain:	n/a
23	chr20:23732873-23732923	U87	brain:	n/a
24	chr20:23732873-23732923	HepG2	liver:	n/a
25	chr20:23731367-23731417	T-47D	breast:	n/a
26	chr20:23732873-23732923	AG09319	gingival:	n/a
27	chr20:23732595-23732645	GM19239	blood:	n/a
28	chr20:23732595-23732645	A549	lung:	n/a
29	chr20:23732873-23732923	HEK293	kidney:	embryo
30	chr20:23731367-23731417	AG09319	gingival:	n/a
31	chr20:23728432-23728482	SK-N-SH	brain:	n/a
32	chr20:23728814-23728864	PrEC	prostate:	n/a
33	chr20:23728432-23728482	U87	brain:	n/a
34	chr20:23731367-23731417	PFSK-1	brain:	n/a
35	chr20:23728814-23728864	GM12891	blood:	n/a
36	chr20:23732873-23732923	AG10803	skin:	n/a
37	chr20:23731367-23731417	AoSMC	blood vessel:	n/a
38	chr20:23732595-23732645	Hela-S3	cervix:	n/a
39	chr20:23732595-23732645	GM06990	blood:	n/a
40	chr20:23728814-23728864	GM12892	blood:	n/a
41	chr20:23732595-23732645	AoSMC	blood vessel:	n/a
42	chr20:23731367-23731417	NHBE	bronchial:	n/a
43	chr20:23728432-23728482	SK-N-SH_RA	brain:	n/a
44	chr20:23732595-23732645	IMR90	lung:	fetal
45	chr20:23728432-23728482	SKMC	muscle:	n/a
46	chr20:23728814-23728864	AG09309	skin:	n/a
47	chr20:23732595-23732645	ProgFib	skin:	n/a
48	chr20:23732595-23732645	Hepatocyte	liver:	n/a
49	chr20:23732595-23732645	HCT-116	colon:	n/a
50	chr20:23731367-23731417	CMK	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr20:23702805..23703439-chr20:23754485..23755364,2	MCF-7	breast:
2	chr20:23645187..23645712-chr20:23775888..23776677,2	MCF-7	breast:
3	chr20:23649188..23649689-chr20:23762769..23763504,2	MCF-7	breast:
4	chr20:23763057..23763763-chr20:23870036..23871243,3	MCF-7	breast:
5	chr20:23704490..23705249-chr20:23762654..23763235,2	MCF-7	breast:
6	chr20:23704491..23705478-chr20:23779622..23780975,4	MCF-7	breast:
7	chr20:23754506..23755505-chr20:23837367..23838288,3	MCF-7	breast:
8	chr20:23704490..23705249-chr20:23762654..23763235,2	MCF-7	breast:
9	chr20:23704352..23705295-chr20:23754423..23755304,4	MCF-7	breast:
10	chr20:23704352..23705295-chr20:23754423..23755304,4	MCF-7	breast:
11	chr20:23648920..23650143-chr20:23704363..23705222,5	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CST8-5	chr20:23733871-23734300	NONHSAT079083
2	lnc-CST8-5	chr20:23732376-23732473	NONHSAT079083
3	lnc-CST8-5	chr20:23733160-23733281	NONHSAT079083
4	lnc-CST8-5	chr20:23726778-23726924	NONHSAT079083

Variant related genes	Relation type
ENSG00000230908	TF binding region
CST1	TF binding region
ENSG00000230908	CpG island
CST1	CpG island

Extended variants
information (count: 2732 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:2732 , 50 per page) page: 1 2 3 4 5 6 7 ... 55

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs534055534	chr20:23713607-23713608	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs547367634	chr20:23713633-23713634	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs34362468	chr20:23713676-23713677	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs4366970	chr20:23713696-23713697	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs534084249	chr20:23713697-23713698	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs576177147	chr20:23713723-23713724	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs116425005	chr20:23713732-23713733	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs555301600	chr20:23713767-23713768	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs4364081	chr20:23713773-23713774	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs181906983	chr20:23713828-23713829	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs4296495	chr20:23713849-23713850	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs577848366	chr20:23713920-23713921	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs186251945	chr20:23713949-23713950	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs369711212	chr20:23713959-23713960	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs563465563	chr20:23713965-23713966	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs529303715	chr20:23713980-23713981	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs549120438	chr20:23713986-23713987	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs535100767	chr20:23713998-23713999	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs148135523	chr20:23714010-23714011	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs556525885	chr20:23714024-23714025	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs3922396	chr20:23714047-23714048	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs4302279	chr20:23714048-23714049	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs570743223	chr20:23714056-23714057	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs545494299	chr20:23714080-23714081	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs577711056	chr20:23714094-23714095	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs539660036	chr20:23714124-23714125	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs549955288	chr20:23714139-23714140	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs557523558	chr20:23714151-23714152	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs569776302	chr20:23714152-23714153	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs35368888	chr20:23714168-23714169	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs118161056	chr20:23714173-23714174	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs555166114	chr20:23714194-23714195	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs114619946	chr20:23714224-23714225	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs534305293	chr20:23714236-23714237	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs115289324	chr20:23714243-23714244	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs374593429	chr20:23714252-23714253	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs35783127	chr20:23714284-23714285	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs28822796	chr20:23714335-23714336	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs370552514	chr20:23714337-23714338	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs543614272	chr20:23714349-23714350	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs191772725	chr20:23714375-23714376	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs137890267	chr20:23714396-23714397	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs60905473	chr20:23714426-23714427	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs559573326	chr20:23714431-23714432	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs181367613	chr20:23714438-23714439	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs545040999	chr20:23714462-23714463	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs34807036	chr20:23714487-23714488	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs550089706	chr20:23714494-23714495	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs569911741	chr20:23714517-23714518	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs533512048	chr20:23714532-23714533	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
small cell lung cancer	17426248	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:206 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23713600-23714200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr20:23714200-23719000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr20:23715200-23716000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr20:23715400-23716400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr20:23719000-23719400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr20:23724800-23726600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr20:23725200-23726800	Enhancers	HUVEC	blood vessel
8	chr20:23725400-23725800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr20:23725400-23725800	Enhancers	Osteobl	bone
10	chr20:23725400-23726000	Enhancers	NHLF	lung
11	chr20:23725400-23726600	Enhancers	NHDF-Ad	bronchial
12	chr20:23725400-23727000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr20:23725600-23725800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr20:23725800-23726200	Enhancers	Muscle Satellite Cultured Cells	--
15	chr20:23725800-23727000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
16	chr20:23726800-23727000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr20:23726800-23731800	Weak transcription	HUVEC	blood vessel
18	chr20:23727000-23727200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr20:23727000-23729600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
20	chr20:23727200-23727800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr20:23727800-23728000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr20:23727800-23728400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
23	chr20:23727800-23728600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr20:23727800-23728800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
25	chr20:23728000-23728600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr20:23728600-23728800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr20:23728600-23729200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr20:23728800-23731400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
29	chr20:23728800-23735000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr20:23729200-23730600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr20:23729600-23734400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr20:23730600-23730800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr20:23730600-23731000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
34	chr20:23730800-23731000	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr20:23730800-23731600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
36	chr20:23731000-23731200	Enhancers	H9 Cell Line	embryonic stem cell
37	chr20:23731000-23732000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr20:23731200-23731400	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
39	chr20:23731400-23731600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr20:23731600-23733600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr20:23731800-23732000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr20:23731800-23732200	Enhancers	HUVEC	blood vessel
43	chr20:23732000-23732800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr20:23732200-23734200	Weak transcription	HUVEC	blood vessel
45	chr20:23732600-23734000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr20:23732800-23733200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr20:23733200-23733600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr20:23733600-23737000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
49	chr20:23733800-23736600	Enhancers	NHDF-Ad	bronchial
50	chr20:23733800-23736800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links